Variable | N = 15 n (%) |
---|---|
Age, years | |
Mean ± SD | 49.8 ± 11.2 |
< 65 | 14 (93.3) |
≥ 65 | 1 (6.7) |
Women | 5 (33.3) |
Body mass index, kg/m2 | |
Mean ± SD | 33.0 (7.4) |
18.5–24.9 | 2 (13.3) |
25.0–29.9 | 3 (20.0) |
≥ 30.0 | 10 (66.7) |
Ethnicity | |
White | 14 (93.3) |
Other | 0 (0.0) |
Triglycerides, mmol/L | |
Mean ± SD | 9.3 ± 9.4 |
Median (range) | 5.8 (3.1, 39.3) |
Total cholesterol, mmol/L | |
Mean ± SD | 5.4 (1.8) |
Median (range) | 5.0 (3.2, 8.4) |
Lipid-lowering medication | |
Fibrates | 14 (93.3) |
Statins | 12 (80.0) |
Cholesterol absorption inhibitors | 3 (20.0) |
History of diabetes | |
Type 1 | 1 (6.7) |
Type 2 | 11 (73.3) |
Any | 12 (80.0) |
Diabetes medication | |
Metformin | 9 (60.0) |
Insulin | 2 (13.3) |
Thiazolidinediones | 2 (13.3) |
Dipeptidyl peptidase-4 inhibitor | 1 (6.7) |
Alpha-glucosidase inhibitor | 1 (6.7) |
Fecal elastase, μg/g | |
n | 14 (93.3) |
Median μg/g (range) | 380 (18–500) |